期刊文献+

原发免疫性血小板减少症患者CD4^+T细胞CD28的表达及其与IFN-γ/IL-10比率的关系 被引量:5

CD28 expression on CD4^+T cells and its relationship with IFN-γ/IL-10 ratio in patients with primary immune thrombocytopenia
下载PDF
导出
摘要 目的研究原发免疫性血小板减少症(ITP)患者治疗前、后,外周血CD4+的T淋巴细胞中共刺激分子CD28的表达及与IFN-γ/IL-10比率的关系。方法采用流式细胞术分析30例ITP患者糖皮质激素治疗前、后和26例正常对照外周血CD4+T细胞上CD28表达率,用ELISA双夹心法检测外周血血清中IFN-γ和IL-10的水平,评价CD4+CD28+与IFN-γ/IL-10平衡状态、血小板计数之间的关系。结果 ITP患者治疗前CD4+CD28+的表达显著高于正常对照组(P<0.05),治疗后与正常对照组比较,差异无统计学意义(P>0.05);ITP患者治疗前IFN-γ水平较正常对照组显著增高,IL-10水平显著降低,IFN-γ/IL-10比值显著增高(P<0.01),治疗后与正常对照组比较,差异无统计学意义(P>0.05);ITP患者治疗前CD4+CD28+与IFN-γ/IL-10比值呈正相关(P<0.05),与血小板计数呈负相关(P<0.05)。结论共刺激分子CD28与ITP免疫紊乱密切相关,可能通过参与Th1优势状态形成而在ITP的发病中发挥一定作用。 Objective To investigate CD28 expression on CD4^ +T cells and its relationship with IFN-γ/IL-10 ration in patients with primary immune thrombocytopenia (ITP) before and after treatment. Methods The expression of CD4^ + CD28 ^+ was detected by flow cytometry, the levels of IFN-γ and IL-10 were determined by double-antibody sandwich ELISA and platelet count was tested by blood cells automatical counter in peripheral blood of 30 patients with ITP before and after glucocorticoid treatment and 26 cases of normal controls. Then the correlations between the outcomes were analyzed. Results The expression of CEH^+ CD28^+ of ITP patients before treatment was higher than that of the normal control group ( P 〈 0. 05), however, after treatment the expression between the two groups had no statistical difference ( P 〉 0.05 ). Compared with the control group, the ITP patients before treatment showed the significantly higher level of IFN-γ and the significantly decreased level of IL-10, and the ratio of IFN-γ/IL-10 was significantly raised (P 〈 0.01 ) ; while ITP patients after treatment had no statistically significant difference in the above indexes from the normal controls (P〉 0.05). Moreover, CD4^+ CD28^+ was positively correlated with IFN-γ/IL-10 ratio (P〈 0.05), and was negatively correlated with platelet count in ITP patients before treatment ( P 〈 0. 05). Condusion Co-stimulatory molecule CD4^+ CD28^+ was closely related with immune disorder of ITP. It maybe played a role in the pathogenesis of ITP through involving Thl advantage state formation.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2013年第8期850-853,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 新疆医科大学第一附属医院科研奖励基金(2010YFY28)
关键词 血小板减少症 自身免疫性 CD4^+CD28^+ T辅助淋巴细胞 thrombocytopenia, auto immune CD4^+ CD28^+ T helper cells
  • 相关文献

参考文献17

  • 1Johnsen J. Pathogenesis in immune thrombocytopenia : new insights[J/ 0A ]. Hematology Am Soc Hematol Educ Program,2012, 2012 :306 -312.
  • 2Li HY, Zhang DL,Ge J, et al. Elevated interleukin-27 enhancesthe polarization of Thl/Tcl cells and the production of proinflamma-tory cytokines in primary immune thrombocytopenia [ J ]. HumImmunol, 2012,73(3) : 240 -247.
  • 3Teke HU, Gundtiz E, Akay OM,et al. Abnormality of regulatory T-cells in remission and non-remission idiopathic thrombocytopenicpurpura patients[ J]. Platelets, 2012 Dec 7. [ Epub ahead of print].
  • 4Catani L, Sollazzo D, Trabanelli S,et al. Decreased expression ofindoleamine 2,3-dioxygenase 1 in dendritic cells contributes to im-paired regulatory T cell development in immune thrombocytopenia[J]. Ann Hematol, 2013,92(1) : 67 -78.
  • 5Zhang Ma D, Zhu X, et al. Elevated profile of Thl7 , Thl andTel cells in patients with immune thrombocytopenic purpura [ J ].Haematologica, 2009, 94(9) : 1327 -1328.
  • 6Sprent J, Surh CD. Normal T cell homeostasis: the conversion ofnaive cells into memory-phenotype cells [J]. Nat Immunol, 2011,12(6) : 478 -484.
  • 7Gu D, Chen Z, Zhao H, et al. Thl (CXCL10) and Th2 ( CCL2)chemokine expression in patients with immune thrombocytopenia[ J].Hum Immunol, 2010, 71(6) : 586 -591.
  • 8Stasi R. Pathophysiology and therapeutic options in primary immunethrombocyt-openia. [ J]. Blood Transfus, 2011, 9: 262-273.
  • 9Moore TV, Clay BS, Cannon JL, et al. Inducible costimulator con-trols migration of T cells to the lungs via down-regulation of CCR7and CD62L[J]. Am J Respir Cell Mol Biol, 2011,45(4) : 843 -850.
  • 10Cao J, Zou L,Luo P, et al. Increased production of circulatingsoluble co-stimulatory molecules CTLA-4,CD28 and CD80 inpatients with rheumatoid arthritis [ J ]. Int Immunopharmacol, 2012,14(4) : 585 -592.

二级参考文献30

  • 1钱莘,施明,王福生.流式细胞术检测细胞内细胞因子的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):62-64. 被引量:10
  • 2王婷婷,赵辉,任贺,郭建海,徐茂强,杨仁池,韩忠朝.慢性特发性血小板减少性紫癜患者Ⅰ类和Ⅱ类T细胞特点的研究[J].中华医学杂志,2006,86(10):669-673. 被引量:18
  • 3SUKATI H,WATSON H G,URBANIAK S J,et al.Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura[J].Blood,2007,109:4528-4538.
  • 4OLSSON B,ANDERSSON P O,JERNAS M,et al.T-cellmediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura[J].Nat Med,2003,9:1123-1124.
  • 5NDEJEMBI M P,TEIJARO J R,PATKE D S,et al.Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway[J].J Immunol,2006,177:7698-7706.
  • 6SANCHEZ-LOCKHART M,MILLER J.Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription[J].J Immunol,2006,176:4778-4784.
  • 7MARINARI B,COSTANZO A,MARZANO V,et al.CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters[J].PNAS,2004,101:6098-6103.
  • 8FIELDS P E,FINCH R J,GRAY G S,et al.B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells[J].J Immunol,1998,161:5268-5275.
  • 9ZHANG P,MARTIN M,YANG Q B,et al.Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis[J].Infect Immun,2004,72:637-644.
  • 10Romagnani S. Thl and Th2 in human diseases [J]. Clin Immunol Immunopathol, 1996, 80(3 Pt 1): 225-235.

共引文献35

同被引文献71

  • 1Li HY,Zhang DL, Ge J,et al. Elevated interleukin-27 enhances the polarization of Th1/Tcl cells and the production of pro-inflammatory cytokines in primary immune thrombocytopenia [ J ]. Hum hnnm- no1,2012,73 ( 3 ) :240-247.
  • 2Teke HU , Gandtiz E , Akay OM ,et al. Abnormality of regulatory Tcells in remission and non-remission idiopathic thrombocytopenic purpura patients [J] . Platelets, 20 13 ,24 ( 8) : 625 -631.
  • 3Catani L, Sollazzo D, Trabanelli S, et al. Decreased expression of indoleamine 2 ,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia [J]. Ann Hematol,2013 ,92(1) :67-78.
  • 4Zhang J , Ma D, Zhu X, et al. Elevated profile of Th17 , Thl and Tel cells in patients with immune thrombocytopenic purpura [J] . Haematologica,2009 ,94(9) : 1327-1328.
  • 5Rodeghiero F, Stasi R, Gernsheimer T, et al: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group[J]. Blood,2009,113(11) :2386-2393.
  • 6Yazdani U, Terman JR. The semaphorins [J] . Genome Bioi ,2006,7 (3) :21101-21114.
  • 7Kumanogoh A, Suzuki K, Ch ' ng E, et al. Requirement for the lymphocyte semaphorln, COl 00, in the induction of antigen specific T cells and the maturation of dendritic cells [J] . J Immunol, 2002,169(3) :1175-1181.
  • 8Wang X, Kumanogoh A, Watanabe C, et al. . Functional soluble COIOO/Sema 4D released from activated lymphocytes: possible role in normal and pathologic immune responses [J]. Blood, 2001,97 (11) :3498-3504.
  • 9Toltl W,Arnold DM. Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters [J]. Br J Haematol,2011, 152( 1) :52-60.
  • 10Park H, Li Z, Yang XO, et al: A distinct lineage of CD4 + T cells regulates tissue inflammation by producing interleukin 17 [J]. Nat Immunol,2005,6(11) :1133-1141.

引证文献5

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部